FIELD: biomedical research.
SUBSTANCE: group of inventions relates to compounds which can be used for diagnosing tumors. Disclosed is a fluorescent conjugate containing a fluorochrome F fragment connected to a targeting moiety T, where fragment F has formula (I):
.
Targeting fragment T has an affinity for the tumor marker. Also disclosed are use of a conjugate for diagnosing tumors in vitro or in vivo, including photodetection of tumor nodes during resection surgical treatment.
EFFECT: disclosed are fluorescent conjugates and use thereof for diagnosing tumors.
24 cl, 4 dwg, 1 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES AGAINST CCR7 RECEPTOR FOR CANCER TREATMENT | 2006 |
|
RU2404808C2 |
| CANCER-MODIFYING ANTIBODIES | 2008 |
|
RU2468036C2 |
| DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS | 2014 |
|
RU2749867C2 |
| NOVEL MODULATORS AND METHODS FOR USE THEREOF | 2011 |
|
RU2592672C9 |
| USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3, IN COMBINATION WITH COSTIMULATION 4-1BB | 2020 |
|
RU2822092C2 |
| NEW MODULATORS AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2627176C2 |
| ANTIBODY SPECIFICALLY BINDING WITH MUC1 AND ITS APPLICATION | 2018 |
|
RU2746413C1 |
| ANTIBODIES SPECIFIC TO TUMOUR AND USE THEREOF | 2011 |
|
RU2595403C2 |
| ANTIBODY SPECIFICALLY BINDING TO ECL-2 CLAUDIN 3, ITS FRAGMENT AND ITS USE | 2019 |
|
RU2768002C1 |
| ANTIBODIES SPECIFIC TO CLAUDIN 6 (CLDN6) | 2010 |
|
RU2675997C2 |
